JPRN-jRCT2080222130未知3 期
A prospective, multicenter, single arm, open-label, phase III study to assess the safety and efficacy of bosentan in patients with digital ulcers associated with systemic sclerosis (SSc)
Actelion Pharmaceuticals Japan Ltd.0 个研究点目标入组 20 人开始时间: 2013年7月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Male and female patients aged 18 years or older who currently have or had an SSc-related digital ulcer within the last 5 years
排除标准
- •Digital ulcers associated with a condition other than SSc.
- •Definitely diagnosed with PAH before starting the study treatment.
研究者
相似试验
已完成
Unknown
A clinical trial to evaluate the efficacy and safety of CareSens Air, a continuous glucose monitor, in adult patients with diabetes.Endocrine, nutritional and metabolic diseasesKCT0009215i-sens85
进行中（未招募）
1 期
Triumeq As an Integrase Single Tablet Regimen in People with HIV who Inject DrugsHuman Immunodeficiency Virus (HIV) infectionEUCTR2016-000087-42-IEniversity College Dublin50
已完成
4 期
A prospective, multicenter, single-arm, open-label, phase 4 study to evaluate the effects of macitentan on Right vEntricular remodeling in Pulmonary ArterIal hypeRtension assessed by cardiac magnetic resonance imagingPulmonary Arterial HypertensionElevated blood pressure in blood vessels in the lungs.10037454NL-OMON45109Actelion Pharmaceuticals15
进行中（未招募）
1 期
A study of the effects of macitentan on the heart in patients with elevated blood pressure in blood vessels of the lungs.MedDRA version: 20.0Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2014-004066-20-DEActelion Pharmaceuticals Ltd.87
进行中（未招募）
1 期
A study of the effects of macitentan on the heart in patients with elevated blood pressure in blood vessels of the lungs.Pulmonary Arterial HypertensionMedDRA version: 20.0 Level: PT Classification code 10064911 Term: Pulmonary arterial hypertension System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-004066-20-GBActelion Pharmaceuticals Ltd.100